SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?


To: wpckr who wrote (717)8/31/1998 2:23:00 PM
From: Harold Engstrom  Read Replies (1) | Respond to of 1686
 
Hirulog was developed by Biogen and licensed to The Medicines Company. If TMC is able to commercialize Hirulog then Biogen will get more money.

Hirulog is an anticoagulent that is marginally safer and more effective than Heparin, but much more expensive.